China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China flag China · Delayed Price · Currency is CNY
18.41
+0.06 (0.33%)
Feb 3, 2026, 1:24 PM CST

SHA:600062 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
18,94720,32318,99218,27613,94812,508
Market Cap Growth
-7.24%7.01%3.92%31.03%11.51%-8.12%
Enterprise Value
18,53619,02416,38116,12411,1809,405
Last Close Price
18.3519.3117.8016.8312.0810.57
PE Ratio
11.9912.4911.3715.4914.9112.44
Forward PE
10.7711.0312.4615.3211.709.97
PS Ratio
1.731.811.681.901.531.47
PB Ratio
1.561.831.471.611.331.33
P/TBV Ratio
2.242.611.992.291.761.69
P/FCF Ratio
19.7417.1115.2620.5516.4212.36
P/OCF Ratio
12.5611.1410.2212.9110.409.20
PEG Ratio
-0.990.990.990.990.99
EV/Sales Ratio
1.691.701.451.681.231.11
EV/EBITDA Ratio
7.588.076.859.077.556.08
EV/EBIT Ratio
11.1611.599.4913.0310.818.02
EV/FCF Ratio
19.3116.0213.1618.1313.169.29
Debt / Equity Ratio
0.100.110.020.030.01-
Debt / EBITDA Ratio
0.470.510.130.160.04-
Debt / FCF Ratio
1.211.030.250.330.07-
Asset Turnover
0.650.640.680.670.700.72
Inventory Turnover
2.932.952.732.422.742.59
Quick Ratio
1.641.411.561.792.082.02
Current Ratio
2.251.871.962.482.762.55
Return on Equity (ROE)
14.12%13.75%13.74%11.32%9.79%11.23%
Return on Assets (ROA)
6.37%5.88%6.46%5.36%4.95%6.19%
Return on Invested Capital (ROIC)
13.94%15.09%16.00%13.57%13.72%16.11%
Return on Capital Employed (ROCE)
12.40%12.90%12.90%10.20%9.40%12.00%
Earnings Yield
8.34%8.01%8.79%6.46%6.71%8.04%
FCF Yield
5.07%5.84%6.55%4.87%6.09%8.09%
Dividend Yield
2.51%2.44%1.44%3.44%3.97%2.74%
Payout Ratio
51.41%90.88%18.31%67.94%32.34%31.77%
Buyback Yield / Dilution
-0.57%-0.33%1.07%0.74%0.00%-0.00%
Total Shareholder Return
1.94%2.11%2.52%4.18%3.97%2.74%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.